Ian Burnstein Joins Wesana Health Advisory Board
TORONTO and CHICAGO, July 14, 2021 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (Wesana or the Company) (CSE: WESA), an emerging data driven life sciences company focused on developing innovative approaches for better understanding, protecting and improving neurological health and performance, including through the advancement of psychedelic medicines, today announced the addition of Ian Burnstein to its Scientific Advisory Board.
- TORONTO and CHICAGO, July 14, 2021 (GLOBE NEWSWIRE) -- Wesana Health Holdings Inc. (Wesana or the Company) (CSE: WESA), an emerging data driven life sciences company focused on developing innovative approaches for better understanding, protecting and improving neurological health and performance, including through the advancement of psychedelic medicines, today announced the addition of Ian Burnstein to its Scientific Advisory Board.
- On his appointment, Burnstein said, Wesanas mission, as well as the energy and commitment that Daniel, Chad, and the board of directors, bring to the pursuit of innovation surrounding TBI, will revolutionize neurological health solutions.
- He will be an important asset as Wesana identifies valuable growth and expansion opportunities, and forms critical partnerships to further our research and treatment objectives, said Daniel Carcillo, co-founder and CEO of Wesana Health.
- Burnstein serves as the president of the board of the Dr. Gary Burnstein Community Health Clinic, which provides free health care in Pontiac, Detroit for more than 8,000 people annually.